Transcriptome Identifies Mechanisms of 1 Regulatory T cell ( Treg ) Suppression of Acute Graft-versus-Host-Disease 2 3
暂无分享,去创建一个
Simonetta | S. Buhler | R. Negrin | J. Villard | Y. Chalandon | Mustafa Turkoz | J. Baker | T. Hirai | J. Lohmeyer | X. Ji | T. Ramos | N. Köhler | 5. Federico | Toshihito Hirai
[1] Chuan-Yuan Li,et al. Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect , 2022, Frontiers in Immunology.
[2] H. von Bernuth,et al. Adoptive transfer of ex vivo expanded regulatory T-cells improves immune cell engraftment and therapy-refractory chronic GvHD. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] W. Cui,et al. Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD , 2022, Blood advances.
[4] A. Shalek,et al. Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq Platform , 2021, bioRxiv.
[5] J. Rathmell,et al. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease , 2021, Frontiers in Immunology.
[6] B. Falini,et al. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia. , 2021, Blood advances.
[7] E. L. Potter,et al. Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease , 2021, Science Translational Medicine.
[8] M. Boerries,et al. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans , 2020, Science Translational Medicine.
[9] W. Linehan,et al. Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI , 2020 .
[10] Marc Ansari,et al. Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation , 2019, Leukemia.
[11] Mark M. Davis,et al. Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis , 2019, Nature.
[12] R. Negrin. Immune regulation in hematopoietic cell transplantation , 2019, Bone Marrow Transplantation.
[13] G. Hill,et al. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. , 2018, Blood.
[14] J. Serody,et al. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease. , 2016, The Journal of clinical investigation.
[15] Lior Pachter,et al. Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.
[16] C. Le,et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. , 2016, Blood.
[17] R. Negrin. Graft-versus-host disease versus graft-versus-leukemia. , 2015, Hematology. American Society of Hematology. Education Program.
[18] M. Florek,et al. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease , 2015, The Journal of Immunology.
[19] J. Pardo,et al. Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease , 2015, PloS one.
[20] J. Rathmell,et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. , 2014, Cell metabolism.
[21] Mark M Davis,et al. Linking T-cell receptor sequence to functional phenotype at the single-cell level , 2014, Nature Biotechnology.
[22] J. Melenhorst,et al. Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity , 2014, Clinical Cancer Research.
[23] J. Ritz,et al. Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease , 2013, Science Translational Medicine.
[24] R. Geffers,et al. Human regulatory T cells in allogeneic stem cell transplantation. , 2011, Blood.
[25] G. Hill,et al. CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis , 2011, Proceedings of the National Academy of Sciences.
[26] B. Falini,et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.
[27] J. Wagner,et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.
[28] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[29] T. Ley,et al. Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. , 2010, Blood.
[30] Z. Berneman,et al. Regulatory T Cells and Human Disease , 2008, Clinical & developmental immunology.
[31] S. Ishihara,et al. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells , 2007, Nature Immunology.
[32] C. Contag,et al. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. , 2007, Blood.
[33] C. Contag,et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. , 2005, Blood.
[34] J. Serody,et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. , 2004, Blood.
[35] Christopher H Contag,et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. , 2003, Blood.
[36] C. Fathman,et al. Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation , 2002, The Journal of experimental medicine.